Reasons for performing study: Antimicrobial intravenous regional limb perfusion (IV-RLP) is clinically performed on anaesthetised or sedated horses with or without regional anaesthesia. To date, no scientific data is available on the clinical and pharmacokinetic effects of these anaesthetic protocols on antimicrobial IV-RLP, which is believed to result in better tourniquet efficiency due to decreased movement.
Introduction
Equine orthopaedic infections are common life-threatening conditions that necessitate early and aggressive treatment including drainage, surgical debridement and antimicrobial therapy. Antimicrobials are frequently administered both systemically and regionally, including intravenous regional limb perfusion (IV-RLP) [1, 2] .
Movement of standing, sedated animals undergoing IV-RLP is believed to cause inadvertent leakage of the perfusate into the systemic circulation due to failure of vascular occlusion by the tourniquet [3, 4] . In an attempt to minimise patient movement, perineural or intravenous regional anaesthesia is sometimes combined with antimicrobial IV-RLP to decrease the horse's discomfort [5, 6] . To the authors' knowledge, an objective evaluation of the effects of these regional anaesthetic techniques on the horse's comfort level and synovial antimicrobial concentrations has not been performed.
Performing IV-RLP under general anaesthesia eliminates patient movement, which might increase regional antimicrobial concentrations due to less vascular leakage; however, general anaesthesia carries an increased risk to the patient [7] and additional costs to the client. Therefore, antimicrobial IV-RLP is commonly performed on standing, sedated horses and it provides high regional antimicrobial concentrations [8] [9] [10] . However, there is no available comparative data on the synovial antimicrobial concentrations after IV-RLP on the standing versus the anaesthetised horse.
This study examined the effects of intravenous regional anaesthesia, perineural regional anaesthesia or general anaesthesia on the horse's comfort level and synovial antimicrobial pharmacokinetics in horses undergoing IV-RLP with amikacin. It was hypothesised that the addition of regional anaesthesia (intravenous or perineural) during IV-RLP would increase the horses' comfort level and the synovial fluid amikacin concentrations compared to IV-RLP without regional anaesthesia in standing, sedated horses. It was further hypothesised that synovial amikacin concentrations after IV-RLP on standing, sedated horses with the concurrent use of intravenous or perineural regional anaesthesia would be similar to those obtained after IV-RLP under general anaesthesia.
Materials and Methods

Animals
Eight clinically healthy, adult, local breed (detail to be provided on acceptance) mares with mean (range) weight and age of 390 (357 -430) kg and 7 (5.5 -10) years, respectively, were included. Inclusion criteria were normal physical examination, absence of lameness at walk and trot, no musculoskeletal abnormalities in the front limbs and no drug administration for at least eight weeks prior to the study. The study was approved by the (detail to be provided on acceptance) Animal Use and Care Committee.
The mares were housed in outdoor sheltered pens with free access to hay and water. Before general anaesthesia food, but not water, was withheld for 6 hours. Daily clinical examinations were performed from the day before treatment until 24 hours after collection of the last sample.
Study design
A prospective, blinded, cross-over study was conducted. Each mare received 4 IV-RLP treatments in a random order, with a wash-out period of one week between treatments. The first treatment was randomly assigned to either the left or right front limb and subsequent treatments alternated between the front limbs. 
IV-RLP
Amikacin measurement
Amikacin concentrations were measured using fluorescence polarization immunoassay [12] (Integra 400 Plus) k , following procedures described by the manufacturer. Synovial fluid was diluted with calibration kit diluent as required for amikacin concentrations to fall within the test range of 3 -40 µg/mL. The measured values were corrected, accordingly, by the dilution factor to obtain the synovial amikacin concentrations
Pharmacokinetic analysis
Regional synovial pharmacokinetic parameters were estimated by a non-compartmental analysis 
Clinical assessment
Assessment of discomfort of the standing, sedated horses undergoing IV-RLP (CNT, IVA and PNA)
was performed by using a visual analogue scale of discomfort (VAS) [13] . The VAS scale consisted of a horizontal line of 100 mm with no markings, with 0 mm representing no discomfort and 100 mm representing severe discomfort (horse becoming aggressive, pawing intensively and/or rearing). The 30-minute period of IV-RLP was subdivided into two 15-minute periods (0 -15 minutes and 15 -30 minutes) and a VAS score was subjectively assigned to each period by the primary author who was blinded to the treatment group. If a horse received additional sedation during the first 15-minute period, a VAS score of 100 was assigned to both the first and second periods. If the first additional sedation was administered during the second period, only the second period was assigned a score of 100. The average of the scores assigned to both periods was calculated and used in the statistical analysis. Lifting of the treated limb during the procedure was also counted and recorded. Heart rate and respiratory rate of each horse were recorded 5 minutes after sedation and before tourniquet placement (baseline) and 15, 30 and 40 minutes after perfusate administration in treatments CNT, IVA and PNA.
Statistical analysis
All the statistical procedures were analysed by Statistical Analysis System (SAS, version 9. transformed before analysis to meet normality assumptions. Post-hoc Tukey-Kramer mean separation was used to identify differences among least squared means. Significant difference was set at P < 0.05.
Results
All horses received all treatments. All general anaesthesia recoveries were uneventful. One mare became recumbent during CNT 29 minutes after perfusate administration and stood up 10 minutes after removal of the tourniquet. The same mare also became recumbent during IVA at 5 minutes and stood up 26 minutes after perfusate administration. In both instances her clinical parameters were within normal limits at 40 minutes after perfusate administration and T1.5. Due to the fact that the mare was recumbent during two of the procedures to be performed standing, she was removed from statistical analysis.
Amikacin measurements and rPkp parameters
One synovial sample (T0.5, treatment GA) was excluded from the analysis due to measurement error. Synovial fluid amikacin concentrations and estimated regional pharmacokinetic parameters for different treatments are included in Figure 1 and Table 1 respectively. No significant differences were found among treatments for any of the regional pharmacokinetic parameters or amikacin concentrations at each time point. All systemic amikacin concentrations at T0 were below the limit of detection of the analytical method.
Mean (range) systemic amikacin concentrations (µg/mL) at T0. 
Clinical assessment
Results of VAS scores, lifting of the limb, heart rate and respiratory rate are summarized in Table 2 .
Significantly lower VAS scores (mean ± SD) were observed with PNA (19 ± 15) compared to CNT (81 ± and respiratory rate were observed among any of the standing treatments at any time.
Discussion
In the present study, the use of perineural regional anaesthesia increased the comfort level of standing, sedated horses undergoing IV-RLP; however, the use of intravenous regional anaesthesia in standing, sedated horses did not have any beneficial clinical effect compared with IV-RLP without regional anaesthesia. In addition, neither the use of regional anaesthetic techniques or general anaesthesia had a significant effect on the regional pharmacokinetic parameters of amikacin in horses undergoing IV-RLP.
The reason for failure of intravenous regional anaesthesia to reduce the discomfort of horses is unclear but might be attributed to pain caused by the tourniquet being located proximal to the desensitized area. In humans, a double cuff tourniquet is used [14, 15] , where the proximal cuff is initially inflated to perform the intravenous injection of the local anaesthetic, which will desensitize the appendage distal to the cuff. Thereafter, the distal cuff, positioned immediately distal to the proximal cuff and on the desensitised area, is inflated, which will maintain vascular isolation of the distal appendage for the duration of the procedure. The proximal cuff, which is located outside the desensitized area, is deflated, thus not contributing to pain or discomfort. To the authors' knowledge, no information is available on the use of double cuff tourniquets in horses. When perineural regional anaesthesia was performed in the present study, the tourniquet was placed on the desensitized area. This might explain the increase in comfort levels in standing, sedated horses with the addition of perineural regional anaesthesia in this study.
A wide elastic tourniquet was used in the present study instead of a pneumatic tourniquet because it is more economical and widely used in clinical practice [16] . Recent studies have shown the use of a wide elastic tourniquet to be comparable [12] or superior [16] to a pneumatic tourniquet in achieving high intrasynovial amikacin concentrations with IV-RLP.
A visual analogue scale is commonly used in horses to evaluate pain [13, 17] and has been shown to have good intra-and inter-observer agreement [18] . The blinded use of this scale proved to be useful to evaluate discomfort of horses in this study and revealed differences in discomfort among different treatments on standing, sedated horses. The results obtained with VAS were supported by lifting of the limb and the number of extra sedations needed, which showed that treatment PNA provided superior comfort to the horses in this study.
The hypothesis that the use of regional anaesthesia during IV-RLP versus IV-RLP without regional anaesthesia on standing horses would result in a significant increase in synovial fluid amikacin concentrations could not be demonstrated in this study, although mean concentrations and regional pharmacokinetic parameters were numerically higher in PNA treatment. A possible contributing factor is the high variability in the synovial amikacin concentrations as observed in previous studies [12, 19, 20] .
This variability might in part be explained by the fact that the dose of amikacin was fixed and not corrected for the animal's weight similar to clinical practice and previous studies [21] . Blood contamination of the synovial fluid samples might have affected the measured intra-synovial amikacin concentrations [21] . However, arthrocentesis of the middle carpal joint is regarded as easy [11] and all arthrocenteses were performed by the primary author in a similar manner.
This study showed that synovial fluid amikacin concentrations after IV-RLP on standing, sedated horses with the concurrent use of regional anaesthesia were similar to those obtained after IV-RLP under general anaesthesia, although mean concentrations and regional pharmacokinetic parameters were numerically higher in GA. Similarly to what has been discussed previously, it is possible that the high variability in the synovial amikacin concentrations precluded any significance. During IV-RLP, venous pressure in the perfused area is influenced by volume of perfusate, rate and site of injection [22] . The maximum venous pressure is the highest achievable intravenous pressure before leakage to the systemic circulation will result and this is a reflection of tourniquet efficacy [22] . Sudden weight shifts on the front limbs of a horse can double intravascular pressure distal to the tourniquet [21] , which might exceed the maximum venous pressure and cause leakage of the perfusate from the isolated area. This has been suggested as a possible cause of perfusate leakage [3, 4, 12] . However, in the present study no significant effect of limb movement on synovial or systemic amikacin concentrations could be demonstrated. It is possible that quantifying the number of times the limb was lifted was not sensitive enough, as either a gentle lift of the limb or an aggressive pawing were quantified similarly.
The reason for recumbency of one mare during CNT and IVA is uncertain, but was interpreted as severe discomfort. This behaviour was not seen in any of the other horses and has not been observed by the authors in the clinical setting. The data obtained from this horse was removed from the analysis since the effect of recumbency on regional pharmacokinetic parameters and clinical parameters is unknown.
This study was performed on healthy horses. In inflamed joints, increased amikacin delivery and clearance from the synovial fluid after IV-RLP have been demonstrated when compared to healthy joints [23] ; therefore, the regional pharmacokinetic parameters obtained with the different treatments in the present study cannot necessarily be directly extrapolated to horses with orthopaedic infections.
A shortcoming of this study is that, although fluorescence polarization immunoassay has been used previously to measure amikacin on equine synovial samples [10, 12, 16, 19, 21 , 23], we did not perform an in-house validation of the assay.
In conclusion, this study shows that the use of perineural regional anaesthesia proximal to the tourniquet alleviates the discomfort of horses more efficiently than intravenous regional anaesthesia when performing IV-RLP on the standing, sedated horse. Therefore, perineural regional anaesthesia can be recommended as a preferred technique for IV-RLP treatments in standing horses. Additionally, the use of regional or general anaesthesia during IV-RLP with amikacin did not significantly affect the regional pharmacokinetic parameters. Thus the use of general anaesthesia for IV-RLP in horses is not justified based on the results of this study.
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